Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen.
Identifieur interne : 000795 ( Main/Exploration ); précédent : 000794; suivant : 000796Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen.
Auteurs : Margaret Lartey [Ghana] ; Kwamena W. Sagoe ; Hongmei Yang ; Ernest Kenu ; Fafa Xexemeku ; Joseph Oliver-Commey ; Vincent Boima ; Markafui Seshie ; Augustine Sagoe ; Julius A A. Mingle ; Timothy P. Flanigan ; Hulin Wu ; Awewura KwaraSource :
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [ 1537-6591 ] ; 2011.
Descripteurs français
- KwdFr :
- Adulte, Agents antiVIH (administration et posologie), Antituberculeux (administration et posologie), Benzoxazines (administration et posologie), Charge virale, Femelle, Humains, Infections à VIH (), Infections à VIH (traitement médicamenteux), Infections à VIH (virologie), Mâle, Thérapie antirétrovirale hautement active (), Tuberculose (), VIH (Virus de l'Immunodéficience Humaine) (isolement et purification), Virémie.
- MESH :
- administration et posologie : Agents antiVIH, Antituberculeux, Benzoxazines.
- isolement et purification : VIH (Virus de l'Immunodéficience Humaine).
- traitement médicamenteux : Infections à VIH.
- virologie : Infections à VIH.
- Adulte, Charge virale, Femelle, Humains, Infections à VIH, Mâle, Thérapie antirétrovirale hautement active, Tuberculose, Virémie.
English descriptors
- KwdEn :
- Adult, Anti-HIV Agents (administration & dosage), Antiretroviral Therapy, Highly Active (methods), Antitubercular Agents (administration & dosage), Benzoxazines (administration & dosage), Female, HIV (isolation & purification), HIV Infections (complications), HIV Infections (drug therapy), HIV Infections (virology), Humans, Male, Tuberculosis (complications), Viral Load, Viremia.
- MESH :
- chemical , administration & dosage : Anti-HIV Agents, Antitubercular Agents, Benzoxazines.
- complications : HIV Infections, Tuberculosis.
- drug therapy : HIV Infections.
- isolation & purification : HIV.
- methods : Antiretroviral Therapy, Highly Active.
- virology : HIV Infections.
- Adult, Female, Humans, Male, Viral Load, Viremia.
Abstract
Viral decay rates during efavirenz-based therapy were compared between human immunodeficiency virus (HIV)-infected patients without tuberculosis (n = 40) and those with tuberculosis coinfection who were receiving concurrent antituberculous therapy (n = 34). Phase I and II viral decay rates were similar in the 2 groups (P > .05). Overall, concurrent antituberculous therapy did not reduce the efficacy of the HIV treatment.
DOI: 10.1093/cid/ciq196
PubMed: 21252140
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000522
- to stream PubMed, to step Curation: 000522
- to stream PubMed, to step Checkpoint: 000522
- to stream Ncbi, to step Merge: 000403
- to stream Ncbi, to step Curation: 000403
- to stream Ncbi, to step Checkpoint: 000403
- to stream Main, to step Merge: 000796
- to stream Main, to step Curation: 000795
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen.</title><author><name sortKey="Lartey, Margaret" sort="Lartey, Margaret" uniqKey="Lartey M" first="Margaret" last="Lartey">Margaret Lartey</name><affiliation wicri:level="1"><nlm:affiliation>University of Ghana Medical School, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>University of Ghana Medical School</wicri:regionArea><placeName><settlement type="city">Accra</settlement><settlement type="town">Legon (Ghana)</settlement><region type="region">Région du Grand Accra</region></placeName><orgName type="university" n="3">Université du Ghana</orgName></affiliation></author><author><name sortKey="Sagoe, Kwamena W" sort="Sagoe, Kwamena W" uniqKey="Sagoe K" first="Kwamena W" last="Sagoe">Kwamena W. Sagoe</name></author><author><name sortKey="Yang, Hongmei" sort="Yang, Hongmei" uniqKey="Yang H" first="Hongmei" last="Yang">Hongmei Yang</name></author><author><name sortKey="Kenu, Ernest" sort="Kenu, Ernest" uniqKey="Kenu E" first="Ernest" last="Kenu">Ernest Kenu</name></author><author><name sortKey="Xexemeku, Fafa" sort="Xexemeku, Fafa" uniqKey="Xexemeku F" first="Fafa" last="Xexemeku">Fafa Xexemeku</name></author><author><name sortKey="Oliver Commey, Joseph" sort="Oliver Commey, Joseph" uniqKey="Oliver Commey J" first="Joseph" last="Oliver-Commey">Joseph Oliver-Commey</name></author><author><name sortKey="Boima, Vincent" sort="Boima, Vincent" uniqKey="Boima V" first="Vincent" last="Boima">Vincent Boima</name></author><author><name sortKey="Seshie, Markafui" sort="Seshie, Markafui" uniqKey="Seshie M" first="Markafui" last="Seshie">Markafui Seshie</name></author><author><name sortKey="Sagoe, Augustine" sort="Sagoe, Augustine" uniqKey="Sagoe A" first="Augustine" last="Sagoe">Augustine Sagoe</name></author><author><name sortKey="Mingle, Julius A A" sort="Mingle, Julius A A" uniqKey="Mingle J" first="Julius A A" last="Mingle">Julius A A. Mingle</name></author><author><name sortKey="Flanigan, Timothy P" sort="Flanigan, Timothy P" uniqKey="Flanigan T" first="Timothy P" last="Flanigan">Timothy P. Flanigan</name></author><author><name sortKey="Wu, Hulin" sort="Wu, Hulin" uniqKey="Wu H" first="Hulin" last="Wu">Hulin Wu</name></author><author><name sortKey="Kwara, Awewura" sort="Kwara, Awewura" uniqKey="Kwara A" first="Awewura" last="Kwara">Awewura Kwara</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21252140</idno><idno type="pmid">21252140</idno><idno type="doi">10.1093/cid/ciq196</idno><idno type="wicri:Area/PubMed/Corpus">000522</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000522</idno><idno type="wicri:Area/PubMed/Curation">000522</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000522</idno><idno type="wicri:Area/PubMed/Checkpoint">000522</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000522</idno><idno type="wicri:Area/Ncbi/Merge">000403</idno><idno type="wicri:Area/Ncbi/Curation">000403</idno><idno type="wicri:Area/Ncbi/Checkpoint">000403</idno><idno type="wicri:Area/Main/Merge">000796</idno><idno type="wicri:Area/Main/Curation">000795</idno><idno type="wicri:Area/Main/Exploration">000795</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen.</title><author><name sortKey="Lartey, Margaret" sort="Lartey, Margaret" uniqKey="Lartey M" first="Margaret" last="Lartey">Margaret Lartey</name><affiliation wicri:level="1"><nlm:affiliation>University of Ghana Medical School, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>University of Ghana Medical School</wicri:regionArea><placeName><settlement type="city">Accra</settlement><settlement type="town">Legon (Ghana)</settlement><region type="region">Région du Grand Accra</region></placeName><orgName type="university" n="3">Université du Ghana</orgName></affiliation></author><author><name sortKey="Sagoe, Kwamena W" sort="Sagoe, Kwamena W" uniqKey="Sagoe K" first="Kwamena W" last="Sagoe">Kwamena W. Sagoe</name></author><author><name sortKey="Yang, Hongmei" sort="Yang, Hongmei" uniqKey="Yang H" first="Hongmei" last="Yang">Hongmei Yang</name></author><author><name sortKey="Kenu, Ernest" sort="Kenu, Ernest" uniqKey="Kenu E" first="Ernest" last="Kenu">Ernest Kenu</name></author><author><name sortKey="Xexemeku, Fafa" sort="Xexemeku, Fafa" uniqKey="Xexemeku F" first="Fafa" last="Xexemeku">Fafa Xexemeku</name></author><author><name sortKey="Oliver Commey, Joseph" sort="Oliver Commey, Joseph" uniqKey="Oliver Commey J" first="Joseph" last="Oliver-Commey">Joseph Oliver-Commey</name></author><author><name sortKey="Boima, Vincent" sort="Boima, Vincent" uniqKey="Boima V" first="Vincent" last="Boima">Vincent Boima</name></author><author><name sortKey="Seshie, Markafui" sort="Seshie, Markafui" uniqKey="Seshie M" first="Markafui" last="Seshie">Markafui Seshie</name></author><author><name sortKey="Sagoe, Augustine" sort="Sagoe, Augustine" uniqKey="Sagoe A" first="Augustine" last="Sagoe">Augustine Sagoe</name></author><author><name sortKey="Mingle, Julius A A" sort="Mingle, Julius A A" uniqKey="Mingle J" first="Julius A A" last="Mingle">Julius A A. Mingle</name></author><author><name sortKey="Flanigan, Timothy P" sort="Flanigan, Timothy P" uniqKey="Flanigan T" first="Timothy P" last="Flanigan">Timothy P. Flanigan</name></author><author><name sortKey="Wu, Hulin" sort="Wu, Hulin" uniqKey="Wu H" first="Hulin" last="Wu">Hulin Wu</name></author><author><name sortKey="Kwara, Awewura" sort="Kwara, Awewura" uniqKey="Kwara A" first="Awewura" last="Kwara">Awewura Kwara</name></author></analytic><series><title level="j">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</title><idno type="eISSN">1537-6591</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Anti-HIV Agents (administration & dosage)</term><term>Antiretroviral Therapy, Highly Active (methods)</term><term>Antitubercular Agents (administration & dosage)</term><term>Benzoxazines (administration & dosage)</term><term>Female</term><term>HIV (isolation & purification)</term><term>HIV Infections (complications)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (virology)</term><term>Humans</term><term>Male</term><term>Tuberculosis (complications)</term><term>Viral Load</term><term>Viremia</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Agents antiVIH (administration et posologie)</term><term>Antituberculeux (administration et posologie)</term><term>Benzoxazines (administration et posologie)</term><term>Charge virale</term><term>Femelle</term><term>Humains</term><term>Infections à VIH ()</term><term>Infections à VIH (traitement médicamenteux)</term><term>Infections à VIH (virologie)</term><term>Mâle</term><term>Thérapie antirétrovirale hautement active ()</term><term>Tuberculose ()</term><term>VIH (Virus de l'Immunodéficience Humaine) (isolement et purification)</term><term>Virémie</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-HIV Agents</term><term>Antitubercular Agents</term><term>Benzoxazines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Agents antiVIH</term><term>Antituberculeux</term><term>Benzoxazines</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Infections</term><term>Tuberculosis</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>HIV</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>VIH (Virus de l'Immunodéficience Humaine)</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Antiretroviral Therapy, Highly Active</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Male</term><term>Viral Load</term><term>Viremia</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Charge virale</term><term>Femelle</term><term>Humains</term><term>Infections à VIH</term><term>Mâle</term><term>Thérapie antirétrovirale hautement active</term><term>Tuberculose</term><term>Virémie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Viral decay rates during efavirenz-based therapy were compared between human immunodeficiency virus (HIV)-infected patients without tuberculosis (n = 40) and those with tuberculosis coinfection who were receiving concurrent antituberculous therapy (n = 34). Phase I and II viral decay rates were similar in the 2 groups (P > .05). Overall, concurrent antituberculous therapy did not reduce the efficacy of the HIV treatment.</div></front></TEI><affiliations><list><country><li>Ghana</li></country><region><li>Région du Grand Accra</li></region><settlement><li>Accra</li><li>Legon (Ghana)</li></settlement><orgName><li>Université du Ghana</li></orgName></list><tree><noCountry><name sortKey="Boima, Vincent" sort="Boima, Vincent" uniqKey="Boima V" first="Vincent" last="Boima">Vincent Boima</name><name sortKey="Flanigan, Timothy P" sort="Flanigan, Timothy P" uniqKey="Flanigan T" first="Timothy P" last="Flanigan">Timothy P. Flanigan</name><name sortKey="Kenu, Ernest" sort="Kenu, Ernest" uniqKey="Kenu E" first="Ernest" last="Kenu">Ernest Kenu</name><name sortKey="Kwara, Awewura" sort="Kwara, Awewura" uniqKey="Kwara A" first="Awewura" last="Kwara">Awewura Kwara</name><name sortKey="Mingle, Julius A A" sort="Mingle, Julius A A" uniqKey="Mingle J" first="Julius A A" last="Mingle">Julius A A. Mingle</name><name sortKey="Oliver Commey, Joseph" sort="Oliver Commey, Joseph" uniqKey="Oliver Commey J" first="Joseph" last="Oliver-Commey">Joseph Oliver-Commey</name><name sortKey="Sagoe, Augustine" sort="Sagoe, Augustine" uniqKey="Sagoe A" first="Augustine" last="Sagoe">Augustine Sagoe</name><name sortKey="Sagoe, Kwamena W" sort="Sagoe, Kwamena W" uniqKey="Sagoe K" first="Kwamena W" last="Sagoe">Kwamena W. Sagoe</name><name sortKey="Seshie, Markafui" sort="Seshie, Markafui" uniqKey="Seshie M" first="Markafui" last="Seshie">Markafui Seshie</name><name sortKey="Wu, Hulin" sort="Wu, Hulin" uniqKey="Wu H" first="Hulin" last="Wu">Hulin Wu</name><name sortKey="Xexemeku, Fafa" sort="Xexemeku, Fafa" uniqKey="Xexemeku F" first="Fafa" last="Xexemeku">Fafa Xexemeku</name><name sortKey="Yang, Hongmei" sort="Yang, Hongmei" uniqKey="Yang H" first="Hongmei" last="Yang">Hongmei Yang</name></noCountry><country name="Ghana"><region name="Région du Grand Accra"><name sortKey="Lartey, Margaret" sort="Lartey, Margaret" uniqKey="Lartey M" first="Margaret" last="Lartey">Margaret Lartey</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000795 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000795 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21252140
|texte= Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21252140" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |